We first evaluated the inhibitory effects of AZD3759 on the proliferation of glioma cells and the evaluated of the regulatory effects of AZD3759 on the EGFR and JAK pathways in glioma cells. The gene discussed is EGFR; the disease is central nervous system cancer.